Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients

作者: Paloma Martín Martorell , Marisol Huerta , Amparo Compañ Quilis , Rosario Abellán , Enrique Seda

DOI: 10.1016/J.CLLC.2017.04.006

关键词:

摘要: … received an EGFR TKI despite not having an EGFR mutation. … single EGFR activating mutations treated with an EGFR TKI … ) for the 5 with coexisting EGFR activating mutations (P = .186…

参考文章(32)
Ilenia Chatziandreou, Panagiota Tsioli, Stratigoula Sakellariou, Ioanna Mourkioti, Ioanna Giannopoulou, Georgia Levidou, Penelope Korkolopoulou, Efstratios Patsouris, Angelica A. Saetta, Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations PLOS ONE. ,vol. 10, pp. e0133859- ,(2015) , 10.1371/JOURNAL.PONE.0133859
Cindy Serdjebi, Johan Gagnière, Jérôme Desramé, Francine Fein, Rosine Guimbaud, Eric François, Thierry André, Jean-François Seitz, Carole Montérymard, Dominique Arsene, Julien Volet, Abakar Abakar-Mahamat, Thierry Lecomte, Véronique Guerin-Meyer, Jean-Louis Legoux, Gaël Deplanque, Pierre Guillet, Joseph Ciccolini, Côme Lepage, Laetitia Dahan, FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients PLOS ONE. ,vol. 10, pp. e0135907- 12 ,(2015) , 10.1371/JOURNAL.PONE.0135907
Xiaoxia Chen, Jie Zhang, Qiong Hu, Xuefei Li, Caicun Zhou, A case of lung adenocarcinoma harboring exon 19 EGFR deletion and EML4-ALK fusion gene. Lung Cancer. ,vol. 81, pp. 308- 310 ,(2013) , 10.1016/J.LUNGCAN.2013.05.003
Dan Cristian Chiforeanu, Leila Dufrenot, Vincent Jauffret, Dominique Dachary, Romain Corre, Alexandra Lespagnol, Gwendoline Soler, Julien Dagher, Véronique Catros, Michèle Le Calve, Jean-Philippe Merlio, Marc-Antoine Belaud-Rotureau, Florian Cabillic, Audrey Gros, Frédéric Dugay, Hugues Begueret, Laura Mesturoux, Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances. Journal of Thoracic Oncology. ,vol. 9, pp. 295- 306 ,(2014) , 10.1097/JTO.0000000000000072
June Koo Lee, Tae Min Kim, Youngil Koh, Se-Hoon Lee, Dong-Wan Kim, Yoon-Kyung Jeon, Doo Hyun Chung, Seok-Chul Yang, Young Tae Kim, Young-Whan Kim, Dae Seog Heo, Yung-Jue Bang, None, Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation. Lung Cancer. ,vol. 77, pp. 460- 463 ,(2012) , 10.1016/J.LUNGCAN.2012.04.012
Lei Wang, Haichuan Hu, Yunjian Pan, Rui Wang, Yuan Li, Lei Shen, Yongfu Yu, Hang Li, Deng Cai, Yihua Sun, Haiquan Chen, PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup PLoS ONE. ,vol. 9, pp. e88291- ,(2014) , 10.1371/JOURNAL.PONE.0088291
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Alice T. Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J. Solomon, Fiona Blackhall, Yi-Long Wu, Michael Thomas, Kenneth J. O'Byrne, Denis Moro-Sibilot, D. Ross Camidge, Tony Mok, Vera Hirsh, Gregory J. Riely, Shrividya Iyer, Vanessa Tassell, Anna Polli, Keith D. Wilner, Pasi A. Jänne, Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer The New England Journal of Medicine. ,vol. 368, pp. 2385- 2394 ,(2013) , 10.1056/NEJMOA1214886
S Li, L Li, Y Zhu, C Huang, Y Qin, H Liu, L Ren-Heidenreich, B Shi, H Ren, X Chu, J Kang, W Wang, J Xu, K Tang, H Yang, Y Zheng, J He, G Yu, N Liang, Coexistence of EGFR with KRAS , or BRAF , or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts British Journal of Cancer. ,vol. 110, pp. 2812- 2820 ,(2014) , 10.1038/BJC.2014.210